Location of Repository

Cost-utility analysis of a national project to reduce hypertension in Israel

By Chaim Yosefy, Gary Ginsberg, Reuven Viskoper, Dror Dicker and Dov Gavish
Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2217271
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (1996). (eds): The Global Burden of Disease.
    2. (2005). [http:www.health.gov.il/english/Pages_E/default.asp?main cat=1&catId=8&PageId=8]. Accessed
    3. (2003). Acute Coronary Syndromes 2002, Israel Center for Disease Control (ICDC) publication
    4. (2002). American diabetes Association: clinical practice recommendation. Diabetes Care
    5. (1996). Blood Pressure as a cardiovascular risk factor. JAMA
    6. (1990). Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet
    7. (2001). Clinical reality of coronary prevention guidelines : a comparison of EROASPIRE I and II in nine countries: EROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Lancet
    8. (1993). Comprehensive individualised nonpharmacological treatment programme for hypertension in physician-nurse clinics: two year follow-up. J Hum Hypertens
    9. Decreasing population blood pressure is not mediated by changes in habitual physical activity.
    10. Dialysis patients in Israel, follow-up indices 1989–2001. Israel Center for Dialysis and Kidney Transplants.
    11. (2005). Elevated Blood Pressure and Risk of End-stage Renal Disease in Subjects Without Baseline Kidney Disease. Arch Intern Med
    12. EUROASPIRE: A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.
    13. (2005). F: Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension
    14. (2003). Gavish D: The Ashkelon Hypertension Detection and Control Program (AHDC Program): a community approach to reducing cardiovascular mortality. Prev Med
    15. (2002). GJ: New National Cholesterol Education Program III guidelines for primary prevention lipid-lowering drug therapy: projected impact on the size, sex, and age distribution of the treatment-eligible population. Circulation
    16. (1996). Global Health Statistics.
    17. (2003). IBPC Investigators: Risk factor profile and achievement of treatment goals among hypertensive patients from the Israeli Blood Pressure Control (IBPC) program – initial cost utility analysis.
    18. (2005). International Drug Price Indicator Guide [http://erc.msh.org/ dmpguide/resultsdetail.cfm?]. Accessed
    19. (2000). Kafonek S: The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipidlowering therapy and achieving low density lipoprotein cholesterol goals. Arch Intern Med
    20. (1996). Korczyn AD: The Tel Aviv Stroke Registry, 3600 Consecutive patients. Stroke
    21. (1988). Kotchen TA: Trends in prevalence, awareness, treatment, and control of hypertension in the United States,
    22. (2001). Macroeconomics and health: investing in health for economic development. Report of the commission on Macroeconomics and health. Geneva: World Health Organization;
    23. (1998). MF: Health and disease management: what is it and where is it going? What is the role of health and disease management in hypertension?
    24. (2006). of Statistics, Statistical Abstract of Israel
    25. (1987). Promoting prevention in primary care: controlled trial of low technology, low cost approach.
    26. (2000). Risks of untreated and treated isolated systolic hypertension in the elderly: metaanalysis of outcome trials. Lancet
    27. (1996). Stavenow L: Cardiovascular risk groups and mortality in an urban swedish male population: the Malmo Preventive Project.
    28. (1999). Women's Health in Israel, Israel Center for Disease Control (ICDC),

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.